Search results for " outbreak"

showing 10 items of 640 documents

Molecular surveillance of norovirus, 2005–16 : an epidemiological analysis of data collected from the NoroNet network

2018

BACKGROUND: The development of a vaccine for norovirus requires a detailed understanding of global genetic diversity of noroviruses. We analysed their epidemiology and diversity using surveillance data from the NoroNet network.METHODS: We included genetic sequences of norovirus specimens obtained from outbreak investigations and sporadic gastroenteritis cases between 2005 and 2016 in Europe, Asia, Oceania, and Africa. We genotyped norovirus sequences and analysed sequences that overlapped at open reading frame (ORF) 1 and ORF2. Additionally, we assessed the sampling date and country of origin of the first reported sequence to assess when and where novel drift variants originated.FINDINGS: W…

0301 basic medicineDatabases FactualvirusesVARIANTSmedicine.disease_causeDisease OutbreaksEMERGENCEfluids and secretions[SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseasesEpidemiologyGenotypeTOOLmedia_commonCaliciviridae InfectionsMolecular Epidemiologyvirus diseasesrespiratory system3. Good healthGastroenteritis[ SDV.MHEP.MI ] Life Sciences [q-bio]/Human health and pathology/Infectious diseasesInfectious DiseasesGeography[SDV.MP.VIR]Life Sciences [q-bio]/Microbiology and Parasitology/VirologyRNA Viral[ SDV.MHEP.HEG ] Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyOUTBREAKSmedicine.medical_specialtyEUROPEGenotypeTRANSMISSIONVIRUSES[ SDV.MP.VIR ] Life Sciences [q-bio]/Microbiology and Parasitology/Virology03 medical and health sciencesSDG 3 - Good Health and Well-beingGenetic driftEnvironmental healthmedicinemedia_common.cataloged_instanceHumansEuropean unionRetrospective StudiesGenetic diversityMolecular epidemiologyNorovirusOutbreakGenetic Variation[SDV.MHEP.HEG]Life Sciences [q-bio]/Human health and pathology/Hépatology and GastroenterologyADULTSdigestive system diseasesEVOLUTION030104 developmental biology3121 General medicine internal medicine and other clinical medicineNorovirushuman activities
researchProduct

Minimal clinically important difference and minimal detectable change of the World Health Organization Disability Assessment Schedule 2.0 (WHODAS 2.0…

2020

Objectives: The aim of this study is to estimate a minimal clinically important difference (MCID) and a minimal detectable change (MDC) of the 12-item WHODAS 2.0 amongst patients with chronic musculoskeletal pain. Design: Cross-sectional cohort study. Setting: Outpatient Physical and Rehabilitation Medicine clinic. Subjects: A total of 1988 consecutive patients with musculoskeletal pain. Interventions: A distribution-based approach was employed to estimate a minimal clinically important difference, a minimal detectable change, and a minimal detectable percent change (MDC%). Results: The mean age of the patients was 48 years, and 65% were women. The average intensity of pain was 6,3 (2.0) po…

MaleMusculoskeletal painSchedule2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)WHODASPhysical Therapy Sports Therapy and Rehabilitationminimal detectable changetuki- ja liikuntaelimetWorld healthDisability assessmentCohort StudiesDisability EvaluationMusculoskeletal PainHumansMedicineskin and connective tissue diseasesmusculoskeletal painPain Measurementbusiness.industryMinimal clinically important differenceminimal clinically important differenceRehabilitationkipuMiddle AgedCross-Sectional StudiesPhysical therapyFemalesense organsWhodasChronic PainbusinessData Collection toolsClinical Rehabilitation
researchProduct

Editorial: The Challenge of New Therapeutic Approaches for Unmet Therapeutic Needs

2020

Pharmacologydrug-designmedicine.medical_specialty2019-20 coronavirus outbreakdrug-design; efficacy/risk ratio; innovative therapies; pharmaceutical innovations; pharmacology innovationCoronavirus disease 2019 (COVID-19)business.industrypharmacology innovationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)lcsh:RM1-950lcsh:Therapeutics. PharmacologyInnovative Therapiesinnovative therapiespharmaceutical innovationsmedicinePharmacology (medical)Intensive care medicinebusinessPharmaceutical innovationsefficacy/risk ratio
researchProduct

Pooled analysis of monocyte distribution width in subjects with SARS‐CoV‐2 infection

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Clinical BiochemistryLetter to the EditorsMonocytesLeukocyte CountMDWmedicineDistribution (pharmacology)Humansmonocyte distribution widthLetter to the EditorCell SizeBiochemistry medicalbusiness.industrySARS-CoV-2MonocyteBiochemistry (medical)COVID-19Meta-analysis monocyte distribution width MDW SARS-CoV-2HematologyGeneral MedicinePrognosisVirologyMeta-analysisPooled analysismedicine.anatomical_structurebusinessInternational Journal of Laboratory Hematology
researchProduct

Comment on “ COVID ‐19 and psoriasis: Is it time to limit treatment with immunosuppressants? A call for action”

2020

2019-20 coronavirus outbreakmedicine.medical_specialtyLetterCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Pneumonia ViralDermatologyBetacoronavirusPsoriasisMedicineHumansPsoriasisLimit (mathematics)LettersLetters to the EditorPandemicsLetter to the Editorbusiness.industrySARS-CoV-2COVID-19General Medicinemedicine.diseaseDermatologyAction (philosophy)businessCoronavirus InfectionsCoronavirus InfectionsImmunosuppressive AgentsDermatologic Therapy
researchProduct

Real-life evaluation of a rapid extraction-free SARS-CoV-2 RT-PCR assay (COVID-19 PCR Fast-L) for the diagnosis of COVID-19.

2021

2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)SARS-CoV-2Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Extraction (chemistry)COVID-19BiologyVirologyPolymerase Chain ReactionSensitivity and SpecificityInfectious DiseasesReal-time polymerase chain reactionLife evaluationVirologyCOVID-19 Nucleic Acid TestingHumansRNA ViralProspective StudiesLetter to the EditorJournal of medical virology
researchProduct

Asymmetric [N–I–N]+halonium complexes in solution?

2020

Assessment of the solution equilibria of [bis(pyridine)iodine(I)]+ complexes by ESI-MS and NMR reveals the preference of iodine(I) to form complexes with a more basic pyridine. Mixtures of symmetric [bis(pyridine)iodine(I)]+ complexes undergo statistical ligand exchange, with a predominant entropic driving force favoring asymmetric systems. The influence of ligand basicity, concentration, temperature, and ligand composition is evaluated. Our findings are expected to facilitate the investigations, and the supramolecular and synthetic applications of halonium ions’ halogen bonds. peerReviewed

inorganic chemicals2019-20 coronavirus outbreakliuoksetLigandMetals and AlloysSupramolecular chemistrychemistry.chemical_elementliganditkompleksiyhdisteetGeneral ChemistryIodineMedicinal chemistryCatalysisSurfaces Coatings and FilmsElectronic Optical and Magnetic MaterialsIonjodichemistry.chemical_compoundchemistryPyridineHalogenMaterials ChemistryCeramics and CompositesHalonium ionChemical Communications
researchProduct

Bayesian Markov switching models for the early detection of influenza epidemics

2008

The early detection of outbreaks of diseases is one of the most challenging objectives of epidemiological surveillance systems. In this paper, a Markov switching model is introduced to determine the epidemic and non-epidemic periods from influenza surveillance data: the process of differenced incidence rates is modelled either with a first-order autoregressive process or with a Gaussian white-noise process depending on whether the system is in an epidemic or in a non-epidemic phase. The transition between phases of the disease is modelled as a Markovian process. Bayesian inference is carried out on the former model to detect influenza epidemics at the very moment of their onset. Moreover, t…

Statistics and ProbabilityEpidemiologyComputer scienceBayesian probabilityMarkov processBayesian inferenceDisease Outbreakssymbols.namesakeBayes' theoremStatisticsInfluenza HumanEconometricsHumansHidden Markov modelModels StatisticalMarkov chainIncidenceBayes TheoremMarkov ChainsMoment (mathematics)Autoregressive modelSpainSpace-Time ClusteringsymbolsRegression AnalysisSentinel Surveillance
researchProduct

Development and validation of the Short Professional Quality of Life Scale based on versions IV and V of the Professional Quality of Life Scale

2020

Background This research presents a short version of the Professional Quality of Life (ProQOL) scale, one of the most frequently used questionnaires in the arena of applied healthcare investigation. It measures burnout (BO), compassion fatigue (CF), and compassion satisfaction (CS). Methods A 9-item version of the ProQOL was developed. In Study 1, this short version, which used items from version IV of the ProQOL, was administered to 817 palliative care professionals from Spain, Argentina, and Brazil. In Study 2, the same nine items, but this time from version V of the ProQOL, were administered to 296 Spanish palliative care professionals. Results Study 1: The Short ProQOL showed an adequat…

AdultCross-Cultural ComparisonMaleCoping (psychology)2019-20 coronavirus outbreakPalliative carecomparación transculturalAttitude of Health PersonnelhumanosArgentinaBurnoutlcsh:Computer applications to medicine. Medical informaticsQuality of life scale03 medical and health sciences0302 clinical medicineSurveys and QuestionnairesHealth careHumans030212 general & internal medicineBurnout ProfessionalCompassion fatigue030504 nursingbusiness.industryResearchPalliative CarePublic Health Environmental and Occupational HealthValidation studyReproducibility of ResultsOccupational stressGeneral MedicineadultoHealth personnelactitud del personal sanitarioProfessional burnoutreproducibilidad de resultadoscuidados paliativosSpainCompassion fatiguecalidad de vidaQuality of Lifelcsh:R858-859.7FemaleOccupational stress0305 other medical sciencePsychologybusinessBrazilClinical psychologyHealth and Quality of Life Outcomes
researchProduct

Hospitalizations for Stroke in France During the COVID-19 Pandemic Before, During, and After the National Lockdown.

2021

Background and Purpose: In France, the entire population was put under a total lockdown from March 17 to May 11, 2020 during the peak of the coronavirus disease 2019 (COVID-19) pandemic. Whether the lockdown had consequences on the management of medical emergencies such as stroke and transient ischemic attack (TIA) has yet to be fully evaluated. This article describes hospitalization rates for acute stroke in 2 French regions that experienced contrasting rates of COVID-19 infection, before, during, and after the nationwide lockdown (January to June 2020). Methods: All patients admitted for acute stroke/TIA into all public and private hospitals of the 2 study regions were included. Data wer…

Male2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)EpidemiologyPandemicmedicineHumanscardiovascular diseasesStrokePandemicsAgedRetrospective StudiesAdvanced and Specialized NursingAged 80 and overEntire populationbusiness.industryIncidence (epidemiology)COVID-19Middle Agedmedicine.diseaseHospitalizationStrokeCommunicable Disease ControlFemaleNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessDemographyStroke
researchProduct